ADMA Biologics, Inc. (ADMA)
9.545
-0.30
(-3.00%)
USD |
NASDAQ |
Aug 24, 16:00
9.545
0.00 (0.00%)
After-Hours: 19:58
ADMA Biologics Debt to Equity Ratio : 0.4994 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4994 |
| March 31, 2026 | 0.5237 |
| December 31, 2025 | 0.1674 |
| September 30, 2025 | 0.1928 |
| June 30, 2025 | 0.2104 |
| March 31, 2025 | 0.2196 |
| December 31, 2024 | 0.2353 |
| September 30, 2024 | 0.4803 |
| June 30, 2024 | 0.751 |
| March 31, 2024 | 0.9201 |
| December 31, 2023 | 1.046 |
| September 30, 2023 | 1.010 |
| June 30, 2023 | 1.032 |
| March 31, 2023 | 1.069 |
| December 31, 2022 | 1.016 |
| September 30, 2022 | 1.521 |
| June 30, 2022 | 1.322 |
| March 31, 2022 | 1.153 |
| December 31, 2021 | 0.729 |
| September 30, 2021 | 0.9903 |
| June 30, 2021 | 0.9081 |
| March 31, 2021 | 0.8902 |
| December 31, 2020 | 1.107 |
| September 30, 2020 | 1.404 |
| June 30, 2020 | 1.297 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.019 |
| December 31, 2019 | 3.235 |
| September 30, 2019 | 2.335 |
| June 30, 2019 | 1.791 |
| March 31, 2019 | 5.722 |
| December 31, 2018 | 2.237 |
| September 30, 2018 | 1.181 |
| June 30, 2018 | 0.8435 |
| March 31, 2018 | 1.877 |
| December 31, 2017 | 1.065 |
| September 30, 2017 | 2.398 |
| June 30, 2017 | 1.179 |
| March 31, 2017 | -1.797 |
| December 31, 2016 | -4.545 |
| September 30, 2016 | -131.95 |
| June 30, 2016 | 5.078 |
| March 31, 2016 | -4.707 |
| December 31, 2015 | 19.16 |
| September 30, 2015 | 3.175 |
| June 30, 2015 | 1.626 |
| March 31, 2015 | 1.123 |
| December 31, 2014 | 2.491 |
| September 30, 2014 | 1.088 |
| June 30, 2014 | 0.8056 |
| March 31, 2014 | 0.6213 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Erasca, Inc. | 0.1236 |
| Krystal Biotech, Inc. | 0.0065 |
| Vericel Corp. | 0.2556 |
| Emergent BioSolutions, Inc. | 1.723 |
| Exelixis, Inc. | 0.09 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 684.21M |
| Total Liabilities (Quarterly) | 276.00M |
| Shareholders Equity (Quarterly) | 408.21M |
| Current Ratio | 6.972 |
| Net Debt Paydown Yield | -1.29% |